Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Intermenstrual bleeding, Pain in extremity, Vaccination site erythema
Clinical narrative: Left arm soreness.; Red mark about the size of a dime around the injection site.; the injection site had a bit of a burning or stinging sensation; my arm was just sore; Menstrual spotting; This is a spontaneous report from a contactable consumer. This consumer (patient) reported that.  A 40-years-old female (Non-pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL3248), dose 2 via an unspecified route of administration, administered in Arm Left on 25Mar2021 10:00 as (At the age of 40-years) DOSE 2, SINGLE for covid-19 immunisation. Medical history included intermenstrual bleeding from an unknown date and unknown if ongoing patient have a recent history of spotting. No Allergies to medications, food, or other products. Concomitant medication included oxymetazoline hydrochloride (CLARITIN ALLERGIC); triamcinolone acetonide (NASACORT); desogestrel, ethinylestradiol (VELIVET); ascorbic acid, betacarotene, biotin, calcium phosphate dibasic, calcium stearate, chromic chloride hexahydrate, copper sulfate, ferrous fumarate, folic acid, magnesium oxide, manganese sulfate, nicotinamide, panax ginseng, pantothenic acid, potassium chloride, potassium iodide, pyridoxine hydrochloride, retinol, riboflavin, sodium molybdate, sodium selenate, vitamin b1 nos, vitamin b12 nos, vitamin d nos, vitamin e nos, zinc oxide (CENTRUM ACTIVE); calcium carbonate, colecalciferol (VITAMIN D 2000) all are taken for an unspecified indication, start and stop date were not reported patient received within 2 weeks of vaccination. Patient was not pregnant at the time of vaccination. No covid prior vaccination. No covid test post vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not diagnose with COVID-19 Prior to vaccination Patient did not been tested for COVID-19 Since the vaccination. No Allergies to medications, food, or other products were reported. The patient previously took first dose of BNT162B2 (Lot number:  EN6203) on 03Mar2021for COVID-19 immunization. On 25Mar2021 10:30 patient experienced Left arm soreness. Red mark about the size of a dime around the injection. May be a half hour after the injection, the injection site had a bit of a burning or stinging sensation but that lasted a version short time. Then later in the afternoon patient arm was just sore. It was reported that the date when patient first became aware of adverse event was 25Mar2021. It was reported that On Mar2021 patient experience Menstrual spotting, starting sometime the day after or days after his second dose (I'm not sure of the exact timing in relation to my vaccination). It was reported that patient had recent history of spotting so didn't think much of it. However, the spotting has been consistent since then and grown increasingly heavier. It was reported that patient read an article today that heaver menstrual cycles or spotting may be a side effect of vaccination. Facility where the most recent COVID-19 vaccine was administered was Workplace clinic. Reporter considered all event was not serious. Patient did not receive any tenement for the events. The outcome of event menstrual spotting was not recovered, and outcome of all other events was recovering.  No follow-up attempts are needed. No further information is expected.